Skip to main content
FDA issues letter regarding lebrikizumab review for atopic dermatitis
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA issues letter regarding lebrikizumab review for atopic dermatitis
User login
Username
Password
Reset your password
Concept
Lead
score
Dermatitis
1
1
Atopic Dermatitis
0
0.99
Biologic Therapy
0
0.53
Monoclonal Antibody
0
0.35
Adolescent Medicine
0
0.18
Cytokines
0
0.18
Interleukin
0
0.18
Specialty
Lead
score
Dermatology
1
1
Family Medicine/Primary Care
0
0.8
Internal Medicine
0
0.9
Pharmacist
0
0.7
Edit Tags